Note: All prices and reports are based on end of the day (EOD) data.
Syngene International Limited (SYNGENE)
What SYNGENE does

Syngene International Limited

What company does?Contract research and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries.
Established1993
Entity typePrivate
HeadquartersIndia
SegmentB2B
Syngene International Limited is a share market listed company in the Healthcare industry . It got listed on NSE on 11-AUG-2015 under the trading symbol SYNGENE. On BSE it is listed under trading symbol SYNGENE. The company operates in Biotechnology , Contract Research Organization (CRO) and Pharmaceutical Services categories.

Company overview

Syngene International Limited is a leading global contract research organization (CRO) that offers integrated drug discovery and development services. Established in 1993, Syngene provides scientific expertise, state-of-the-art infrastructure, and flexible business models to support its clients in accelerating the discovery and development of novel therapeutics.

The company's comprehensive suite of services includes medicinal chemistry, biology, toxicology, process R&D, formulation development, analytical development, and cGMP manufacturing. Syngene caters to an extensive range of global pharmaceutical and biotechnology companies across various therapeutic areas such as oncology, immunology & inflammation, metabolic disorders & complications associated with diabetes mellitus.

One of the key factors that sets Syngene apart from its competitors is its focus on innovation. The company consistently invests in cutting-edge technologies to enhance efficiency and productivity in drug discovery processes. For instance,Syngene’s technology platforms encompass advanced capabilities like structural biology (X-ray crystallography), genomics solutions using next-generation sequencing (NGS), virtual screening software for computational drug design among others.

Besides its internal advancements through robust research facilities at Biocon Park - Bengaluru; the company has also entered into strategic partnerships with industry leaders including Amgen Inc., Baxter Healthcare Corporation along with collaborations with academic institutions fostering innovative research while expanding their service offerings.

In addition to delivering high-quality science-based solutions tailored to meet specific client needs effectively; Syngene's commitment towards sustainability by implementing green initiatives has garnered significant attention within CRO sector.

Disclaimer :

All prices or any other data provided here is based on previous day's closing price.

Trading or investing involves a high level of risk, including the loss of all of your investment. No information on our website should be interpreted as an investment / trading suggestion. We are not providing any kind of financial tips or recommendations. We just provide the data that you can analyse yourself and make your own decision. You are solely responsible for any of your action.

We are not SEBI registered analysts. Our website or any person associated with our website are not liable for any kind of losses, fees or charges etc.

We have tried our best to keep the data accuracy. But still we don't guarantee that our data is accurate and up to date. Verify the accuracy of data from official sources like NSE and BSE websites.

Any brand names, trademarks, or copyrighted materials used on this website are for informational purposes only. We disclaim any ownership or rights to such third-party copyrighted materials.

Stocklyzer

At stocklyzer, we provide financial tools, guides and data analysis to help you to make your decision in the financial market.

Contact us
Contact us for any kind of inquiry contact@stocklyzer.com Contact form
Stocklyzer.com © Copyright 2023. All Rights Reserved.